EPOR and plasma cell myeloma: Examination of primary myeloma cells for their putative active EPO/EPOR signaling revealed that all samples (MM-51-MM-54) exhibited activation of both ERK-1/2 and JAK-2 after 5 min treatment with 10 U/ml rhEPO (Fig. 3c).